


























![]()
Q1: 2026-05-11 Earnings Summary
EPS of -$0.04 beats by $0.06
|
Revenue of
$627.78M
(-76.15% Y/Y)
misses by $16.86M
Accendra Health, Inc. (ACH) Shareholder/Analyst Call May 14, 2026 9:00 AM EDT
Company Participants
Mark Beck
Heath Galloway - Executive VP, General Counsel & Corporate Secretary
Edward Pesicka - President, CEO & Director
Presentation
Operator
Hello, and welcome to the Annual Meeting of Shareholders of Accendra Health, Inc. Please note that today's meeting is being recorded. During the meeting, you can submit questions or comments at any time by clicking on the Q&A tab.
It is my pleasure to turn today's meeting over to Mark Beck, Chair of the Board of Directors of Accendra Health. Mr. Beck, the floor is yours.
Mark Beck
Thank you, operator, and good morning. I am Mark Beck, Chair of the Board of Accendra Health. In accordance with the notice of the meeting, I hereby call the Annual Meeting of the Shareholders of Accendra Health, Inc. to order. Along with my fellow directors and the executive officers of the company who have joined our webcast, I would like to welcome you to our annual meeting. We appreciate your attendance at our virtual meeting, your interest in our company and most importantly, your support of Accendra Health.
After we conduct the annual meeting and voting on proposals, Ed Pesicka, President and CEO of Accendra Health, will share some comments with you before we conclude this meeting -- this morning.
Participating in the annual meeting are Heath Galloway, Executive Vice President, General Counsel and Corporate Secretary of the company; and Sandra Moore with Computershare, who will serve as the inspector of election.
We will proceed with the formal business of the meeting as set forth in your notice of annual meeting contained in our proxy statement that the meeting will be conducted in accordance with the rules of conduct that are available on the meeting site. Shareholders may
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。